
FDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase 2 AZUR-1 results.
Supplements and Featured Publications
about 27 years ago
Introductionabout 27 years ago
Clinical Considerations of Depressionabout 27 years ago
Strategies for Effective Management of Depression in Primary Careabout 27 years ago
Collaborative Care Models for the Treatment of Depressionabout 27 years ago
Clinical Pharmacology of Antidepressantsabout 27 years ago
Selected Abstractsabout 27 years ago
CME Quizabout 27 years ago
Bibliography





